Despite decades of improvement to the available insulin preparations, it remains difficult to achieve glycemic control in T1D patients, and complications resulted from poorly controlled blood glucose levels become a common event (Bluestone et al. 2021). This evidence concerns the gene INS and type 1 diabetes mellitus.